Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 18 and up Men only

Treatment for fathers dealing with substance misuse and family violence

Official title: Substance Misuse and Family Violence Treatment for Fathers

Run by Yale University · NCT06650267 · Data updated 2026-11-12

This study tests if the Fathers for Change program can help dads struggling with substance misuse and family violence more than regular drug counseling.

More Child Abuse trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexMen only
Enrollment280 (estimated)
SponsorYale University
Academic / other
Locations2 sites (New Haven, Connecticut and 1 other locations)
StatusRecruiting
StartedFebruary 17, 2025
Main results expectedDecember 31, 2029
Study endsDecember 31, 2030
Registry record updatedMay 22, 2026
Trial IDNCT06650267 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are fathers with a substance use disorder who have reported family violence within the last 18 months and have at least one biological child aged 1 to 12 years.

Probably not a fit

Patients with active protective orders, severe substance addiction requiring detoxification, or untreated severe mental health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of the Fathers for Change (F4C) program compared to Individual Drug Counseling (IDC) in a randomized controlled trial involving 280 fathers undergoing substance use treatment. The trial aims to reduce substance misuse and family violence at the end of treatment and during follow-ups at 3 and 6 months. It also seeks to document improvements in emotion regulation as a mechanism for the observed reductions in substance use and family violence. Participants will be recruited from community and veterans healthcare settings.

Why it matters

Potential benefit: If successful, this study could lead to more effective treatment options for fathers struggling with substance misuse and family violence, ultimately improving family dynamics and child well-being.

How similar studies have gone: Other studies have shown promise in similar interventions targeting substance misuse and family violence, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* meet DSM-5 criteria for an SU disorder at the time of assessment at APT or VACHS;
* report FV within the last 18 months prior to screening (based on self, court, police or child protection reports);
* have at least one biological child aged 1 to 12 years with whom they live or have at least twice per month in person visits;
* are able to complete assessments in English; and
* agree to have their female coparents (mother of the youngest child) contacted for participation of their youngest child. If a participant has more than one child in the age range, the youngest will be the target of assessment and treatment.

Exclusion Criteria:

* an active full/no contact protective order pertaining to their child;
* physiological addiction to a substance that requires detoxification (such individuals may be re-evaluated following detox);
* cognitive impairment (a mini mental state score \<25);
* current untreated psychotic/bipolar disorder;
* currently suicidal or homicidal based on Brief Symptom Inventory Screening and follow-up on positive responses; or
* are currently receiving weekly individual therapy for Substance misuse or family violence

Where it's running

  • Yale University Child Study Center
    New Haven, Connecticut, United States
    Recruiting
  • APT Foundation
    West Haven, Connecticut, United States
    Recruiting

Study contacts

  • Principal investigator: Carla S Stover, Ph.D. — Yale University
  • Study coordinator: Carla S Stover, Ph.D.
  • Email: carla.stover@yale.edu
  • Phone: 2037853486

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.